Hexa Reports Industry Chemotherapy Induced Neutropenia Market

Chemotherapy Induced Neutropenia Market Development and
Product Analysis by Region to 2017
“Chemotherapy-induced neutropenia is a very common side effect of cancer
treatment. Symptoms include severe fatigue, weakness, anxiety, lack of
energy, shortness of breath, headaches, pale appearance, rapid heart rate or
palpitations.”
Chemotherapy-induced neutropenia is a very common side effect of cancer treatment. Symptoms include
severe fatigue, weakness, anxiety, lack of energy, shortness of breath, headaches, pale appearance, rapid
heart rate or palpitations, chest pain dizziness and abdominal pain. The predisposing factors include age, co-
morbidities and time course of therapy.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Chemotherapy Induced Neutropenia Pipeline Review, H2
2017, provides comprehensive information on the therapeutics under development for Chemotherapy
Induced Neutropenia (Toxicology), complete with analysis by stage of development, drug target, mechanism
of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and development history and latest news
and press releases.
Browse Detail Report With TOC @
http://www.hexareports.com/report/chemotherapy-induced-neutropenia-pipeline-review-h2-2017
Follow Us: